Drug Information

Drug General Information
Drug ID
D0B5LF
Former ID
DAP001537
Drug Name
Ximelegatran
Drug Type
Small molecular drug
Indication Atrial fibrillation; Venous thromboembolism; Myocardial infarction [ICD9: 410, 427.31, 453; ICD10:I21, I22, I48, I80-I82] Approved [536186]
Company
AstraZeneca
Structure
Download
2D MOL

3D MOL
Formula
C14H21N3O
Canonical SMILES
CC(C1CCC(CC1)C(=O)NC2=CC=NC=C2)N
InChI
1S/C14H21N3O/c1-10(15)11-2-4-12(5-3-11)14(18)17-13-6-8-16-9-7-13/h6-12H,2-5,15H2,1H3,(H,16,17,18)/t10-,11?,12?/m1/s1
InChIKey
IYOZTVGMEWJPKR-VOMCLLRMSA-N
CAS Number
CAS 192939-46-1
PubChem Compound ID
448042
PubChem Substance ID
830156, 841201, 7891193, 8028485, 11120129, 11120617, 11121105, 11121802, 11122282, 11147212, 11362988, 11365550, 11368112, 11371127, 11371128, 11373713, 11376274, 11532694, 11532697, 14798541, 14847630, 17422547, 26753164, 26753165, 34932925, 36890023, 46392966, 46394059, 46394196, 46394199, 46514394, 47216599, 47365003, 47440057, 48034921, 48259041, 50074632, 50105663, 50105664, 53787296, 57404850, 80086449, 85787251, 85787299, 90340876, 92310153, 99301065, 99302585, 99437221, 99445227
SuperDrug ATC ID
B01AE05
SuperDrug CAS ID
cas=192939461
Target and Pathway
KEGG Pathway Neuroactive ligand-receptor interaction
Complement and coagulation cascades
Regulation of actin cytoskeleton
NetPath Pathway TCR Signaling Pathway
PANTHER Pathway Blood coagulation
Pathway Interaction Database Thrombin/protease-activated receptor (PAR) pathway
Angiopoietin receptor Tie2-mediated signaling
FOXA2 and FOXA3 transcription factor networks
PAR4-mediated thrombin signaling events
Syndecan-4-mediated signaling events
PAR1-mediated thrombin signaling events
PathWhiz Pathway Vitamin K Metabolism
Coagulation
Reactome Intrinsic Pathway of Fibrin Clot Formation
Common Pathway of Fibrin Clot Formation
Gamma-carboxylation of protein precursors
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
Removal of aminoterminal propeptides from gamma-carboxylated proteins
Cell surface interactions at the vascular wall
Peptide ligand-binding receptors
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
G alpha (q) signalling events
Thrombin signalling through proteinase activated receptors (PARs)
WikiPathways Complement and Coagulation Cascades
Regulation of Actin Cytoskeleton
IL1 and megakaryotyces in obesity
Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
PTM: gamma carboxylation, hypusine formation and arylsulfatase activation
Blood Clotting Cascade
Gastrin-CREB signalling pathway via PKC and MAPK
Thrombin signalling through proteinase activated receptors (PARs)
Platelet Aggregation (Plug Formation)
GPCR ligand binding
GPCR downstream signaling
Formation of Fibrin Clot (Clotting Cascade)
Cell surface interactions at the vascular wall
Folate Metabolism
Vitamin B12 Metabolism
Selenium Micronutrient Network
References
Ref 536186Emerging drugs in peripheral arterial disease. Expert Opin Emerg Drugs. 2006 Mar;11(1):75-90.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.